FDA Approved: MAXALT-MLT — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for MAXALT-MLT (rizatriptan benzoate) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• MAXALT-MLT (Rizatriptan benzoate)

Snippet

SUPPL AP for MAXALT-MLT (RIZATRIPTAN BENZOATE)